Label: BENZONATATE capsule

  • NDC Code(s): 64980-634-01, 64980-634-50, 64980-635-01, 64980-635-50
  • Packager: Rising Pharma Holdings, Inc.
  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated June 7, 2024

If you are a consumer or patient please visit this version.

  • DESCRIPTION
    Benzonatate, a non-narcotic oral antitussive agent, is 2, 5, 8, 11, 14, 17, 20, 23, 26-nonaoxaoctacosan-28-yl p-(butylamino) benzoate; with a molecular weight of 603.7. Each benzonatate capsule ...
  • CLINICAL PHARMACOLOGY
    Benzonatate Capsule acts peripherally by anesthetizing the stretch receptors located in the respiratory passages, lungs, and pleura by dampening their activity and thereby reducing the cough ...
  • INDICATIONS AND USAGE
    Benzonatate Capsule is indicated for the symptomatic relief of cough.
  • CONTRAINDICATIONS
    Hypersensitivity to benzonatate or related compounds.
  • WARNINGS
    Hypersensitivity - Severe hypersensitivity reactions (including bronchospasm, laryngospasm and cardiovascular collapse) have been reported which are possibly related to local anesthesia from ...
  • PRECAUTIONS
    Benzonatate is chemically related to anesthetic agents of the para-amino-benzoic acid class (e.g. procaine; tetracaine) and has been associated with adverse CNS effects possibly related to a prior ...
  • ADVERSE REACTIONS
    Potential Adverse Reactions to Benzonatate Capsules may include: Hypersensitivity reactions including bronchospasm, laryngospasm,cardiovascular collapse possibly related to local anesthesia from ...
  • OVERDOSAGE
    Intentional and unintentional overdose may result in death, particularly in children. The drug is chemically related to tetracaine and other topical anesthetics and shares various aspects of their ...
  • DOSAGE AND ADMINISTRATION
    Adults and Children over 10 years of age - Usual dose is one 100 mg or 200 mg capsule three times a day as needed for cough. If necessary to control cough, up to 600 mg daily in three divided ...
  • HOW SUPPLIED
    Benzonatate Capsules USP, 100 mg are available as yellow, oval soft gelatin capsules with‘1’imprinted in white ink. Bottles of 100 - NDC 64980-634-01 - Bottles of 500 - NDC 64980-634-50 - Benzonatate ...
  • SPL UNCLASSIFIED SECTION
    Manufactured by: CSPC Ouyi Pharmaceutical Co., Ltd. Shijiazhuang, Hebei, China, 052160 - JI20150136 - Distributed By: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816 - Issued: 03/2024
  • PRINCIPAL DISPLAY PANEL - 100 mg Capsule Bottle Label
    NDC 64980-634-01 - Benzonatate Capsules USP - 100 mg - Rx only - 100 CAPSULES - Rising Pharma Holdings, Inc.
  • PRINCIPAL DISPLAY PANEL - 200 mg Capsule Bottle Label
    NDC 64980-635-01 - Benzonatate Capsules USP - 200 mg - Rx only - 100 CAPSULES - Rising Pharma Holdings, Inc.
  • INGREDIENTS AND APPEARANCE
    Product Information